nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PSMD1—pancreas—sclerosing cholangitis	0.0815	0.1	CbGeAlD
Bortezomib—PSMD2—pancreas—sclerosing cholangitis	0.0722	0.0889	CbGeAlD
Bortezomib—PSMB8—pancreas—sclerosing cholangitis	0.0718	0.0884	CbGeAlD
Bortezomib—PSMB5—pancreas—sclerosing cholangitis	0.0634	0.0781	CbGeAlD
Bortezomib—PSMA1—liver—sclerosing cholangitis	0.0618	0.0761	CbGeAlD
Bortezomib—PSMB1—pancreas—sclerosing cholangitis	0.0554	0.0683	CbGeAlD
Bortezomib—PSMB2—pancreas—sclerosing cholangitis	0.0541	0.0666	CbGeAlD
Bortezomib—PSMD1—liver—sclerosing cholangitis	0.0519	0.0639	CbGeAlD
Bortezomib—PSMD2—liver—sclerosing cholangitis	0.0459	0.0566	CbGeAlD
Bortezomib—PSMB8—liver—sclerosing cholangitis	0.0457	0.0562	CbGeAlD
Bortezomib—PSMB5—liver—sclerosing cholangitis	0.0403	0.0497	CbGeAlD
Bortezomib—PSMB1—liver—sclerosing cholangitis	0.0353	0.0434	CbGeAlD
Bortezomib—PSMB2—liver—sclerosing cholangitis	0.0344	0.0424	CbGeAlD
Bortezomib—SLC31A1—liver—sclerosing cholangitis	0.0298	0.0367	CbGeAlD
Bortezomib—CYP2C19—liver—sclerosing cholangitis	0.0126	0.0155	CbGeAlD
Bortezomib—CYP2C8—liver—sclerosing cholangitis	0.011	0.0135	CbGeAlD
Bortezomib—CYP1A2—liver—sclerosing cholangitis	0.0103	0.0126	CbGeAlD
Bortezomib—CYP1A1—liver—sclerosing cholangitis	0.0101	0.0125	CbGeAlD
Bortezomib—CYP2C9—liver—sclerosing cholangitis	0.00973	0.012	CbGeAlD
Bortezomib—CYP3A4—liver—sclerosing cholangitis	0.00742	0.00914	CbGeAlD
Bortezomib—CYP2D6—liver—sclerosing cholangitis	0.0073	0.009	CbGeAlD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00612	0.0325	CbGpPWpGaD
Bortezomib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00607	0.0322	CbGpPWpGaD
Bortezomib—PTGS1—Eicosanoid Synthesis—GGT1—sclerosing cholangitis	0.00595	0.0316	CbGpPWpGaD
Bortezomib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00577	0.0307	CbGpPWpGaD
Bortezomib—PSMA1—Apoptosis—BCL2L11—sclerosing cholangitis	0.00552	0.0293	CbGpPWpGaD
Bortezomib—PSMD1—Apoptosis—BCL2L11—sclerosing cholangitis	0.0055	0.0292	CbGpPWpGaD
Bortezomib—PSMD2—Apoptosis—BCL2L11—sclerosing cholangitis	0.00547	0.0291	CbGpPWpGaD
Bortezomib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00493	0.0262	CbGpPWpGaD
Bortezomib—PSMB5—Apoptosis—BCL2L11—sclerosing cholangitis	0.00419	0.0222	CbGpPWpGaD
Bortezomib—PSMB1—Apoptosis—BCL2L11—sclerosing cholangitis	0.00419	0.0222	CbGpPWpGaD
Bortezomib—PSMB2—Apoptosis—BCL2L11—sclerosing cholangitis	0.00419	0.0222	CbGpPWpGaD
Bortezomib—PSMB8—Apoptosis—BCL2L11—sclerosing cholangitis	0.00413	0.0219	CbGpPWpGaD
Bortezomib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00381	0.0202	CbGpPWpGaD
Bortezomib—PSMA1—Amino acid and derivative metabolism—GOT2—sclerosing cholangitis	0.00335	0.0178	CbGpPWpGaD
Bortezomib—PSMD1—Amino acid and derivative metabolism—GOT2—sclerosing cholangitis	0.00334	0.0177	CbGpPWpGaD
Bortezomib—PSMD2—Amino acid and derivative metabolism—GOT2—sclerosing cholangitis	0.00332	0.0176	CbGpPWpGaD
Bortezomib—PTGS1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00331	0.0176	CbGpPWpGaD
Bortezomib—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00322	0.0171	CbGpPWpGaD
Bortezomib—CYP1A1—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.00302	0.0161	CbGpPWpGaD
Bortezomib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00296	0.0157	CbGpPWpGaD
Bortezomib—PSMA1—Amino acid and derivative metabolism—GOT1—sclerosing cholangitis	0.00289	0.0154	CbGpPWpGaD
Bortezomib—PSMD1—Amino acid and derivative metabolism—GOT1—sclerosing cholangitis	0.00288	0.0153	CbGpPWpGaD
Bortezomib—PSMD2—Amino acid and derivative metabolism—GOT1—sclerosing cholangitis	0.00287	0.0152	CbGpPWpGaD
Bortezomib—PSMB5—Amino acid and derivative metabolism—GOT2—sclerosing cholangitis	0.00254	0.0135	CbGpPWpGaD
Bortezomib—PSMB1—Amino acid and derivative metabolism—GOT2—sclerosing cholangitis	0.00254	0.0135	CbGpPWpGaD
Bortezomib—PSMB2—Amino acid and derivative metabolism—GOT2—sclerosing cholangitis	0.00254	0.0135	CbGpPWpGaD
Bortezomib—PSMB8—Amino acid and derivative metabolism—GOT2—sclerosing cholangitis	0.00251	0.0133	CbGpPWpGaD
Bortezomib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00249	0.0132	CbGpPWpGaD
Bortezomib—CYP1A1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00233	0.0124	CbGpPWpGaD
Bortezomib—PSMB5—Amino acid and derivative metabolism—GOT1—sclerosing cholangitis	0.00219	0.0116	CbGpPWpGaD
Bortezomib—PSMB1—Amino acid and derivative metabolism—GOT1—sclerosing cholangitis	0.00219	0.0116	CbGpPWpGaD
Bortezomib—PSMB2—Amino acid and derivative metabolism—GOT1—sclerosing cholangitis	0.00219	0.0116	CbGpPWpGaD
Bortezomib—PSMB8—Amino acid and derivative metabolism—GOT1—sclerosing cholangitis	0.00216	0.0115	CbGpPWpGaD
Bortezomib—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00214	0.0113	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.0021	0.0112	CbGpPWpGaD
Bortezomib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00204	0.0108	CbGpPWpGaD
Bortezomib—CYP2C19—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00191	0.0101	CbGpPWpGaD
Bortezomib—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00174	0.00924	CbGpPWpGaD
Bortezomib—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00149	0.00789	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—ABCB4—sclerosing cholangitis	0.0013	0.00688	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—ABCB4—sclerosing cholangitis	0.00129	0.00685	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—ABCB4—sclerosing cholangitis	0.00128	0.00682	CbGpPWpGaD
Bortezomib—PTGS1—Biological oxidations—GGT1—sclerosing cholangitis	0.00123	0.00654	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00115	0.00612	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—ABCB4—sclerosing cholangitis	0.000982	0.00522	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—ABCB4—sclerosing cholangitis	0.000982	0.00522	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—ABCB4—sclerosing cholangitis	0.000982	0.00522	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—ABCB4—sclerosing cholangitis	0.000968	0.00514	CbGpPWpGaD
Bortezomib—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.000945	0.00502	CbGpPWpGaD
Bortezomib—CYP1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.000867	0.00461	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000812	0.00431	CbGpPWpGaD
Bortezomib—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.000795	0.00422	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000745	0.00396	CbGpPWpGaD
Bortezomib—PSMA1—Disease—GOT2—sclerosing cholangitis	0.000735	0.0039	CbGpPWpGaD
Bortezomib—PSMD1—Disease—GOT2—sclerosing cholangitis	0.000732	0.00389	CbGpPWpGaD
Bortezomib—PSMD2—Disease—GOT2—sclerosing cholangitis	0.000728	0.00387	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000727	0.00386	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000723	0.00384	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00072	0.00382	CbGpPWpGaD
Bortezomib—CYP2C19—Biological oxidations—GGT1—sclerosing cholangitis	0.00071	0.00377	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000665	0.00353	CbGpPWpGaD
Bortezomib—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.000653	0.00347	CbGpPWpGaD
Bortezomib—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.000647	0.00344	CbGpPWpGaD
Bortezomib—PSMA1—Disease—GOT1—sclerosing cholangitis	0.000635	0.00337	CbGpPWpGaD
Bortezomib—PSMD1—Disease—GOT1—sclerosing cholangitis	0.000632	0.00335	CbGpPWpGaD
Bortezomib—PSMD2—Disease—GOT1—sclerosing cholangitis	0.000629	0.00334	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—GOT2—sclerosing cholangitis	0.000616	0.00327	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—GOT2—sclerosing cholangitis	0.000613	0.00325	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—GOT2—sclerosing cholangitis	0.00061	0.00324	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000606	0.00322	CbGpPWpGaD
Bortezomib—PSMB2—Disease—GOT2—sclerosing cholangitis	0.000557	0.00296	CbGpPWpGaD
Bortezomib—PSMB1—Disease—GOT2—sclerosing cholangitis	0.000557	0.00296	CbGpPWpGaD
Bortezomib—PSMB5—Disease—GOT2—sclerosing cholangitis	0.000557	0.00296	CbGpPWpGaD
Bortezomib—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.000553	0.00294	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000551	0.00293	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000551	0.00293	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000551	0.00293	CbGpPWpGaD
Bortezomib—PSMB8—Disease—GOT2—sclerosing cholangitis	0.000549	0.00292	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000543	0.00288	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—GOT1—sclerosing cholangitis	0.000531	0.00282	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—GGT1—sclerosing cholangitis	0.000531	0.00282	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—GOT1—sclerosing cholangitis	0.000529	0.00281	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—GGT1—sclerosing cholangitis	0.000529	0.00281	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—GOT1—sclerosing cholangitis	0.000526	0.0028	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—GGT1—sclerosing cholangitis	0.000526	0.0028	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000518	0.00275	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ABCB4—sclerosing cholangitis	0.000513	0.00273	CbGpPWpGaD
Bortezomib—PSMB2—Disease—GOT1—sclerosing cholangitis	0.000481	0.00255	CbGpPWpGaD
Bortezomib—PSMB1—Disease—GOT1—sclerosing cholangitis	0.000481	0.00255	CbGpPWpGaD
Bortezomib—PSMB5—Disease—GOT1—sclerosing cholangitis	0.000481	0.00255	CbGpPWpGaD
Bortezomib—PSMB8—Disease—GOT1—sclerosing cholangitis	0.000474	0.00252	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000473	0.00251	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—GOT2—sclerosing cholangitis	0.000467	0.00248	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—GOT2—sclerosing cholangitis	0.000467	0.00248	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—GOT2—sclerosing cholangitis	0.000467	0.00248	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—GOT2—sclerosing cholangitis	0.00046	0.00244	CbGpPWpGaD
Bortezomib—PSMA1—Disease—HIF1A—sclerosing cholangitis	0.000441	0.00234	CbGpPWpGaD
Bortezomib—PSMD1—Disease—HIF1A—sclerosing cholangitis	0.000439	0.00233	CbGpPWpGaD
Bortezomib—PSMD2—Disease—HIF1A—sclerosing cholangitis	0.000437	0.00232	CbGpPWpGaD
Bortezomib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000427	0.00227	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—GOT1—sclerosing cholangitis	0.000403	0.00214	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—GOT1—sclerosing cholangitis	0.000403	0.00214	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—GOT1—sclerosing cholangitis	0.000403	0.00214	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—GGT1—sclerosing cholangitis	0.000403	0.00214	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—GGT1—sclerosing cholangitis	0.000403	0.00214	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—GGT1—sclerosing cholangitis	0.000403	0.00214	CbGpPWpGaD
Bortezomib—PSMA1—Disease—NOS2—sclerosing cholangitis	0.000402	0.00213	CbGpPWpGaD
Bortezomib—PSMD1—Disease—NOS2—sclerosing cholangitis	0.0004	0.00212	CbGpPWpGaD
Bortezomib—PSMD2—Disease—NOS2—sclerosing cholangitis	0.000398	0.00211	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—GGT1—sclerosing cholangitis	0.000397	0.00211	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—GOT1—sclerosing cholangitis	0.000397	0.00211	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000362	0.00192	CbGpPWpGaD
Bortezomib—PSMB5—Disease—HIF1A—sclerosing cholangitis	0.000335	0.00178	CbGpPWpGaD
Bortezomib—PSMB1—Disease—HIF1A—sclerosing cholangitis	0.000335	0.00178	CbGpPWpGaD
Bortezomib—PSMB2—Disease—HIF1A—sclerosing cholangitis	0.000335	0.00178	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000333	0.00177	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.000332	0.00176	CbGpPWpGaD
Bortezomib—PSMB8—Disease—HIF1A—sclerosing cholangitis	0.00033	0.00175	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000309	0.00164	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000308	0.00163	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000306	0.00163	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000305	0.00162	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NOS2—sclerosing cholangitis	0.000304	0.00162	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NOS2—sclerosing cholangitis	0.000304	0.00162	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NOS2—sclerosing cholangitis	0.000304	0.00162	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NOS2—sclerosing cholangitis	0.0003	0.00159	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ABCB4—sclerosing cholangitis	0.000296	0.00157	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000273	0.00145	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000272	0.00145	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.00027	0.00143	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000249	0.00132	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GOT2—sclerosing cholangitis	0.000244	0.0013	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000234	0.00124	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000234	0.00124	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000234	0.00124	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000231	0.00123	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000231	0.00123	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000212	0.00113	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GGT1—sclerosing cholangitis	0.000211	0.00112	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GOT1—sclerosing cholangitis	0.000211	0.00112	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000178	0.000945	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GOT2—sclerosing cholangitis	0.000172	0.000913	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	0.000158	0.000837	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GOT1—sclerosing cholangitis	0.000148	0.000788	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GGT1—sclerosing cholangitis	0.000148	0.000788	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GOT2—sclerosing cholangitis	0.000141	0.000747	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	0.000136	0.000722	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	0.000136	0.000722	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	0.000129	0.000687	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	0.000128	0.000681	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GGT1—sclerosing cholangitis	0.000121	0.000645	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GOT1—sclerosing cholangitis	0.000121	0.000645	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	0.000112	0.000593	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	0.000112	0.000593	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	0.000111	0.000588	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	0.000111	0.000588	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	0.00011	0.000582	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	9.46e-05	0.000502	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	9.46e-05	0.000502	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	8.46e-05	0.000449	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	7.3e-05	0.000388	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	7.3e-05	0.000388	CbGpPWpGaD
